398 related articles for article (PubMed ID: 7923295)
1. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
[TBL] [Abstract][Full Text] [Related]
2. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Baczkó I; Leprán I; Papp JG
Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
4. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
5. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia.
Galiñanes M; Shattock MJ; Hearse DJ
Cardiovasc Res; 1992 Nov; 26(11):1063-8. PubMed ID: 1291083
[TBL] [Abstract][Full Text] [Related]
6. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
7. K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias.
Remme CA; Schumacher CA; de Jong JW; Fiolet JW; de Groot JR; Coronel R; Wilde AA
J Cardiovasc Pharmacol; 2001 Sep; 38(3):406-16. PubMed ID: 11486245
[TBL] [Abstract][Full Text] [Related]
8. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
9. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
Fabiani ME; Story DF
Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
Tosaki A; Das DK
J Pharmacol Exp Ther; 1997 Jul; 282(1):309-17. PubMed ID: 9223569
[TBL] [Abstract][Full Text] [Related]
11. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
[TBL] [Abstract][Full Text] [Related]
12. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart.
Bril A; Laville MP; Gout B
Cardiovasc Res; 1992 Nov; 26(11):1069-76. PubMed ID: 1291084
[TBL] [Abstract][Full Text] [Related]
13. Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.
Han X; Light PE; Giles WR; French RJ
J Physiol; 1996 Jan; 490 ( Pt 2)(Pt 2):337-50. PubMed ID: 8821133
[TBL] [Abstract][Full Text] [Related]
14. Effects of cromakalim or pinacidil on pacing- and ischemia-induced ventricular fibrillation in the anesthetized pig.
D'Alonzo AJ; Hess TA; Darbenzio RB; Sewter JC; Conder ML; McCullough JR
Basic Res Cardiol; 1994; 89(2):163-76. PubMed ID: 8074640
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
16. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Satoh E; Yanagisawa T; Taira N
Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
[TBL] [Abstract][Full Text] [Related]
17. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
18. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
Fabiani ME; Vlahos R; Story DF
Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019
[TBL] [Abstract][Full Text] [Related]
19. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
Wahl M; Parsons AA; Schilling L
Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]